Hypera SA (BSP:HYPE3)
R$ 28.96 -0.32 (-1.09%) Market Cap: 18.32 Bil Enterprise Value: 25.68 Bil PE Ratio: 10.92 PB Ratio: 1.52 GF Score: 88/100

Q4 2021 Hypera SA Earnings Call Transcript

Feb 25, 2022 / 02:00PM GMT
Release Date Price: R$33.5 (+2.79%)
Operator

Good morning, and welcome to Hypera Pharma's Conference Call for the Earnings of 2021. We have with us Mr. Breno Oliveira, CEO; and Mr. Adalmario Couto, Investor Relations Director. We'd like to inform you that this event is being recorded. (Operator Instructions) We'd like to inform you that questions may be asked through a phone connection. If you're connected through the webcast, you should send your question to the Investor Relations team to [email protected]. This is being broadcast online in our Investor Relations website hypera.com.br/ir.

We would like to inform you that some of the information in this conference call might be projections about our future expectations, which are subject to known and unknown risks and uncertainties that may cause these expectations not to materialize or to be substantially different from expected.

I will now pass it on to Mr. Breno Oliveira, who will begin his presentation. Mr. Breno, over to you.

Breno Toledo Pires de Oliveira
Hypera S.A. - CEO

Good morning, everyone. Welcome to our earnings call for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot